Scientific publications
Are Immune Checkpoint Inhibitors Effective Against Uncommon Oncogene-Driven NSCLC Subtypes?
Apr 1, 2020
| Magazine: Journal of Thoracic Oncology
Iñaki Eguren-Santamaria, Miguel F Sanmamed, Ignacio Gil-Bazo
No abstract available.
CITATION J Thorac Oncol. 2020 Apr;15(4):489-492. doi: 10.1016/j.jtho.2020.02.003.
Our authors
Specialist
Medical Oncology Department
Navarre headquarters